Literature DB >> 8562920

Induction of cellular procoagulant activity by the membrane attack complex of complement.

P J Sims1, T Wiedmer.   

Abstract

In addition to their well-recognized role in immune defense, there is a growing recognition that the proteins of the complement system impact directly on vascular homeostatic mechanisms, evoking cellular responses that serve to both promote adherence of blood cells to the walls of blood vessels, and the formation of fibrin through the enzyme mechanisms of the coagulation system. This clot-promoting or 'procoagulant' activity initiated through the complement system entails both receptor-mediated as well as receptor-independent pathways of cell activation. In this review, we will focus specifically upon the role that is now thought to be played by the membrane attack complex of the complement system (MAC) in the induction of the procoagulant properties of human platelets and endothelium.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8562920     DOI: 10.1006/scel.1995.0037

Source DB:  PubMed          Journal:  Semin Cell Biol        ISSN: 1043-4682


  17 in total

Review 1.  Modulation of complement membrane attack by local C7 synthesis.

Authors:  R Würzner
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

Review 2.  Deficiencies of the complement MAC II gene cluster (C6, C7, C9): is subtotal C6 deficiency of particular evolutionary benefit?

Authors:  R Würzner
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

3.  Influence of nanoporesize on platelet adhesion and activation.

Authors:  Natalia Ferraz; Jan Carlsson; Jaan Hong; Marjam Karlsson Ott
Journal:  J Mater Sci Mater Med       Date:  2008-04-15       Impact factor: 3.896

Review 4.  Complement in ANCA-associated vasculitis: mechanisms and implications for management.

Authors:  Min Chen; David R W Jayne; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2017-03-20       Impact factor: 28.314

5.  C6 produced by macrophages contributes to cardiac allograft rejection.

Authors:  Z Qian; B A Wasowska; E Behrens; D L Cangello; J R Brody; S S Kadkol; L Horwitz; J Liu; C Lowenstein; A D Hess; F Sanfilippo; W M Baldwin
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

Review 6.  Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.

Authors:  Tilo Freiwald; Behdad Afzali
Journal:  Adv Immunol       Date:  2021-11-19       Impact factor: 3.543

Review 7.  Endothelial cells in allograft rejection.

Authors:  Rafia S Al-Lamki; John R Bradley; Jordan S Pober
Journal:  Transplantation       Date:  2008-11-27       Impact factor: 4.939

Review 8.  Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndrome.

Authors:  Heather Kerr; Anna Richards
Journal:  Immunobiology       Date:  2011-07-30       Impact factor: 3.144

Review 9.  Mechanisms of signal transduction activated by sublytic assembly of terminal complement complexes on nucleated cells.

Authors:  F Niculescu; H Rus
Journal:  Immunol Res       Date:  2001       Impact factor: 4.505

10.  Hemocompatibility of Inorganic Physical Vapor Deposition (PVD) Coatings on Thermoplastic Polyurethane Polymers.

Authors:  Juergen M Lackner; Wolfgang Waldhauser; Paul Hartmann; Franz Bruckert; Marianne Weidenhaupt; Roman Major; Marek Sanak; Martin Wiesinger; Daniel Heim
Journal:  J Funct Biomater       Date:  2012-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.